U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT06908707) titled 'A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal Women' on March 27.
Brief Summary: The purpose of the study is to evaluate the safety, tolerability and pharmacokinetics (PK) of LAE102 in healthy postmenopausal women
Study Start Date: April 22
Study Type: INTERVENTIONAL
Condition:
Postmenopausal
Healthy Adult Female Participants
Intervention:
DRUG: LAE102 SC
A single dose of LAE102 will be administered subcutaneously
DRUG: Placebo SC
A single dose of placebo administered subcutaneously
DRUG: LAE102 IV
A single dose of LAE102 administered intravenously
DRUG: Placebo IV
A single...